Bebtelovimab in the Real World: Promise and Fulfillment

J Infect Dis. 2022 Nov 11;226(10):1681-1682. doi: 10.1093/infdis/jiac347.
No abstract available

Keywords: SARS-CoV-2; bebtelovimab; nirmatrelvir-ritonavir.

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Ritonavir
  • SARS-CoV-2*

Substances

  • Ritonavir
  • bebtelovimab